E1	Condition:T1 Name:T2 Temporality:E7
E4	Age:T14 Eq-Comparison:E3
E5	Eq-Comparison:T20 Operator:T9 Temporal-Unit:T13 Value:T19
E6	Eq-Comparison:T21 Temporal-Period:T22
E7	Eq-Comparison:T23 Operator:T24 Value:T17 Temporal-Unit:T11
E8	Temporal-Connection:T25 Arg:E14 Arg2:E15
E9	Temporal-Connection:T27 Arg:E5 Arg2:E25
E2	Or:T3 Arg:T6 Arg2:T5
E3	Eq-Comparison:T4 Operator:T7 Temporal-Unit:T10 Value:T15
E10	Temporal-Connection:T16 Arg:E7 Arg2:E11
E11	Study:T29
E12	Observation:T30 Name:T31
E13	Observation:T32 Name:T33 Temporality:E14
E14	Eq-Comparison:T34 Operator:T8 Temporal-Unit:T12 Value:T18
E15	Eq-Comparison:T26 Temporal-Recency:T35
E16	Procedure:T36 Temporality:E15
E17	Drug:T37 Name:T38
E18	Study:T39 Temporality:E6
E19	Condition:T40 Name:T41
E20	Condition:T42 Name:T43
E21	Or:T44 Arg:E19 Arg2:E20
E22	Procedure:T45 Temporality:E5
E23	Drug:T46
E24	Study:T47 Study-Of:E23
E25	Study:T28
E26	Drug:T48 Name:T49
E27	Condition:T50 Name:T51
T1	Condition 589 575	type 2 diabetes
T2	Condition-Name 589 575	type 2 diabetes
T5	Life-Stage-And-Gender 471 460	female
T6	Life-Stage-And-Gender 461 450	Male
T7	Eq-Operator 499 487	greater than or equal
T8	Eq-Operator 710 691	less than or equal
T9	Eq-Operator 1068 1043	within
T10	Eq-Temporal-Unit 512 499	years
T11	Eq-Temporal-Unit 608 593	weeks
T12	Eq-Temporal-Unit 723 703	weeks
T13	Eq-Temporal-Unit 1077 1051	days
T14	Age 477 465	age
T15	Eq-Value 506 493	18
T17	Eq-Value 602 587	12
T18	Eq-Value 717 697	12
T19	Eq-Value 1072 1046	90
T20	Eq-Comparison 1077 1051	within 90 days
T21	Eq-Comparison 804 782	Previous
T22	Eq-Temporal-Period 804 782	Previous
T23	Eq-Comparison 608 593	at least 12 weeks
T25	Temporal-Connection 732 712	prior to
T27	Temporal-Connection 1086 1060	prior to
T3	Or 464 453	or
T4	Eq-Comparison 512 499	greater than or equal to 18 years
T16	Temporal-Connection 617 602	prior to
T24	Eq-Operator 598 584	at least
T29	Study 627 612	inclusion
T30	Observation 674 658	haemoglobin A1c
T31	Observation-Name 674 658	haemoglobin A1c
T32	Observation 683 665	HbA1c
T33	Observation-Name 683 665	HbA1c
T34	Eq-Comparison 723 703	less than or equal to 12 weeks
T26	Eq-Comparison 743 723	initiation
T35	Eq-Temporal-Recency 743 723	initiation
T36	Procedure 768 748	treatment
T37	Drug 758 738	semaglutide
T38	Drug-Name 758 738	semaglutide
T39	Study 832 810	study
T40	Condition 930 906	Mental incapacity
T41	Condition-Name 930 906	Mental incapacity
T42	Condition 967 942	language barriers
T43	Condition-Name 967 942	language barriers
T44	Or 949 924	or
T45	Procedure 1031 1006	Treatment
T46	Drug 1061 1036	drug
T47	Study 1056 1031	investigational
T28	Study 1111 1085	study
T48	Drug 1148 1122	semaglutide
T49	Drug-Name 1148 1122	semaglutide
T50	Condition 1133 1107	Hypersensitivity
T51	Condition-Name 1133 1107	Hypersensitivity
A1	Life-Stage-And-Gender-Type T5 female
A2	Life-Stage-And-Gender-Type T6 male
A3	Eq-Operator-Value T7 GTEQ
A4	Eq-Operator-Value T8 LTEQ
A5	Eq-Operator-Value T9 LTEQ
A6	Eq-Temporal-Unit-Value T10 year
A7	Eq-Temporal-Unit-Value T11 week
A8	Eq-Temporal-Unit-Value T12 week
A9	Eq-Temporal-Unit-Value T13 day
A10	Eq-Temporal-Period-Value T22 past
A11	Temporal-Connection-Type-Value E10 before
A14	Eq-Operator-Value T24 GTEQ
A15	Observation-Type-Value T31 lab
A16	Observation-Type-Value T33 lab
A17	Temporal-Connection-Type-Value E8 before
A12	Eq-Temporal-Recency-Value T35 first-time
A13	Temporal-Connection-Type-Value E9 before
R1	Abbrev-Of Arg1:E13 Arg2:E12
R2	Using Arg1:E16 Arg2:E17
R3	Using Arg1:E22 Arg2:E23
R4	Caused-By Arg1:E27 Arg2:E26